Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.

Autor: Greenspan SL, Emkey RD, Bone HG III, Weiss SR, Bell NH, Downs RW Jr., McKeever C, Miller SS, Davidson M, Bolognese MA, Mulloy AL, Heyden N, Wu M, Kaur A, Lombardi A, Greenspan, Susan L, Emkey, Ronald D, Bone, Henry G, Weiss, Stuart R, Bell, Norman H

Publikováno v: Annals of Internal Medicine; 12/3/2002, Vol. 137 Issue 11, p875-I31, 10p

Osteoporosis After Long-Term Depot Medroxyprogesterone: We Need More Data on Fracture Risk.

Autor: Downs RW Jr; School of Medicine, Virginia Commonwealth University , Richmond, Virginia., Yazbeck CF; School of Medicine, Virginia Commonwealth University , Richmond, Virginia.

Publikováno v: Journal of women's health (2002) [J Womens Health (Larchmt)] 2015 Aug; Vol. 24 (8), pp. 619-20.

Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass.

Autor: Downs RW Jr; Program for Osteoporosis and Bone Health, Division of Endocrinology and Metabolism, Virginia Commonwealth University, 1101 E Marshall Street, 7-015, P.O. Box 980111, Richmond, VA 23298-0111, USA. rdowns@mcvh-vcu.edu, Moffett AM, Ghosh A, Cox DA, Dowsett SA, Harper K

Publikováno v: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2010 Jul; Vol. 21 (7), pp. 1215-26. Date of Electronic Publication: 2009 Oct 02.

Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry.

Autor: Baim S; Rheumatic Disease Center, Glendale, Wisconsin, USA., Wilson CR, Lewiecki EM, Luckey MM, Downs RW Jr, Lentle BC

Publikováno v: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry [J Clin Densitom] 2005 Winter; Vol. 8 (4), pp. 371-8.

Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial.

Autor: Kanis JA; WHO Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. w.j.pontefract@sheffield.ac.uk, Johnell O, Black DM, Downs RW Jr, Sarkar S, Fuerst T, Secrest RJ, Pavo I

Publikováno v: Bone [Bone] 2003 Sep; Vol. 33 (3), pp. 293-300.